相关实验视频
Updated: Mar 12, 2026

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
23.4K
抗脂抗体和心血管血栓形成
Sina Rashedi1,2, Hannah Leyva1,2, Saman A Siddiqui3
1Division of Cardiovascular Medicine, Brigham and Women's Hospital and Heart and Vascular Institute, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Nature reviews. Cardiology
|March 11, 2026
概括
抗脂抗体 (aPL) 增加了血栓形成的风险,特别是在抗脂综合征. 本综述研究了aPL在不同患者群体中的血清阳性及其在预测心血管事件中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 抗脂抗体 (aPL) 向脂和相关蛋白质.
- aPL可以通过前血栓和抗纤维解质途径诱导内皮功能障碍和高凝血能力.
- 这些机制,特别是与辅助因子,有助于静脉和动脉血栓形成.
研究的目的:
- 对有或没有先前血栓形成的个体的aPL血清阳性的证据进行审查.
- 评估aPL在预测血栓性心血管事件中的临床相关性.
- 讨论管理策略和确定研究缺口.
主要方法:
- 对抗脂抗体研究的文献综述.
- 对aPL检测的血清学和功能实验室检测的分析.
- 评估临床结果,包括血栓事件和心血管风险.
主要成果:
- aPL血清阳性与血栓形成风险增加有关,特别是在抗脂综合征中.
- aPL在血栓形成中的作用越来越多地被认为超出了传统标准.
- 有证据表明aPL血清阳性预测血栓性心血管事件.
结论:
- aPL血清阳性是血栓形成和心血管事件的重要危险因素.
- 需要进一步的研究来完善对aPL.aPL患者的管理策略.
- 了解aPL更广泛的临床影响对于患者护理至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis I: Introduction
609
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
609
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Peripheral Artery Disease I: Introduction
521
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Venous Thrombosis III: Interprofessional Care
445
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
445
Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K

